855 related articles for article (PubMed ID: 16959581)
1. Hypertension and diabetes: role of the renin-angiotensin system.
Jandeleit-Dahm K; Cooper ME
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
[TBL] [Abstract][Full Text] [Related]
2. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
Cooper ME
Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
[TBL] [Abstract][Full Text] [Related]
3. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
4. [Control of arterial pressure in diabetic nephropathy].
Luño J; García de Vinuesa S
Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
[No Abstract] [Full Text] [Related]
5. Hypertension and diabetes: epidemiologic aspects as a guide to management.
Fuller JH
J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S63-6. PubMed ID: 7692153
[TBL] [Abstract][Full Text] [Related]
6. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
7. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
Abuissa H; O'Keefe J
Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
9. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
Karalliedde J; Viberti G
J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.
Estacio RO
Postgrad Med; 2009 May; 121(3):33-44. PubMed ID: 19491538
[TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
Tikellis C; Cooper ME; Thomas MC
Int J Biochem Cell Biol; 2006; 38(5-6):737-51. PubMed ID: 16198140
[TBL] [Abstract][Full Text] [Related]
12. [Microalbuminuria is an early marker for increased morbidity and mortality].
Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
[TBL] [Abstract][Full Text] [Related]
13. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system.
Cooper ME; Tikellis C; Thomas MC
J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575
[TBL] [Abstract][Full Text] [Related]
14. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
Boucek P
Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
[TBL] [Abstract][Full Text] [Related]
16. [Hypertension in patients with diabetes].
Poulsen PL; Hansen KW; Gaede PH; Rossing P
Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
18. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
Abassi Z; Winaver J; Feuerstein GZ
Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
[TBL] [Abstract][Full Text] [Related]
19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
20. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
